Kodiak Sciences Inc

is a biopharmaceutical company focused on developing breakthrough therapeutic treatments for retinal diseases and other serious eye conditions. The company specializes in creating innovative therapies that harness the potential of biologics to address significant unmet medical needs in the field of ophthalmology. Its research is aimed at providing long-term solutions with the goal of improving patients' vision and quality of life, while also reducing the burden on healthcare systems. Through its advanced drug development programs, Kodiak is committed to pioneering new standards of care in eye health.